retatrutide and fatty liver Researchers are reporting promising results from studies on an experimental medication called retatrutide, which may help reduce fat while improving overall metabolic health. 🧬⚡ Excess liver fat is a key feature Obesity and Metabolic Dysfunction-associated Fatty

The GLP-1R is expressed in many tissues, including pancreatic islets, the central nervous system, lung, kidney, heart, intestine, and also on immune cells ( When secreted by L cells, GLP-1 either functions in an endocrine manner, being released into the blood stream where it is rapidly inactivated by DPP-4 with a half-life of about 2 min, or exerts paracrine effects like stimulating neurons

Quality assurance practices, such as batch testing and documentation, help strengthen patient trust, particularly when compounded alternatives are the only option

Even patients who dont lose weight on GLP-1s will often still see improvements in blood sugar if they have diabetes

Careful monitoring therefore remains essential, particularly when prescribing to younger individuals or those with a psychiatric history

This timeline does not affect research availability

Insulin mRNA has been found in type II and III cells, and insulin secretion from taste cells has now been confirmed [139]